Abstract
Plasma glucose is tightly regulated via the secretion of the two glucose-regulating hormones insulin and glucagon. Situated next to the insulin-secreting β-cells, the α-cells produce and secrete glucagon—one of the body’s few blood glucose-increasing hormones. Diabetes is a bihormonal disorder, resulting from both inadequate insulin secretion and dysregulation of glucagon. The year 2023 marks the 100th anniversary of the discovery of glucagon, making it particularly timely to highlight the roles of this systemic metabolic messenger in health and disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout



References
Cryer, P. E. Comprehensiv. Physiol. https://doi.org/10.1002/cphy.cp070235 (2011).
Frayn, K. & Evans, R. Human Metabolism: A Regulatory Perspective 4th edn (Wiley Blackwell, 2019).
Gromada, J., Franklin, I. & Wollheim, C. B. Endocr. Rev. 28, 84–116 (2007).
Müller, T. D. et al. Physiol. Rev. 97, 721–766 (2017).
Andersen, D. B. & Holst, J. J. Peptides 148, 170683 (2021).
Lee, Y. H. et al. Diabetologia 59, 1372–1375 (2016).
Albrechtsen, N. J. W. et al. Endocr. Rev. 40, 1353–1366 (2019).
Lefèbvre, P. J. Diabetes Obes. Metab. 13, 1–4 (2011).
Ahrén, B. Peptides 67, 74–81 (2015).
Kimball, C. P. & Murlin, J. R. J. Biol. Chem. 58, 337–346 (1923).
Kim, A. et al. eLife 10, e72919 (2021).
Blackard, W. G., Nelson, N. C. & Andrews, S. S. Diabetes 23, 199–202 (1974).
Amisten, S. et al. Pharmacol. Therapeut. 139, 359–391 (2013).
Perry, R. J. et al. Nature 579, 279–283 (2020).
Campos, R. V., Lee, Y. C. & Drucker, D. J. Endocrinology 134, 2156–2164 (1994).
Bomholt, A. B. et al. Commun. Bio. 5, 1278 (2022).
Ramnanan, C. J. et al. Diabetes Obes Metab. 13, 118–125 (2011).
Gravholt, C. H. et al. J. Clin. Endocrinol. Metab. 86, 2085–2089 (2001).
El, K., Capozzi, M. E. & Campbell, J. E. Endocrinology 161, bqaa169 (2020).
Vasileva, A. et al. Am. J. Physiol. Endoc. M 323, E389–E401 (2022).
Dean, E. D. et al. Cell. Metab. 25, 1362–1373 (2017).
Kim, J. et al. Cell Metab. 25, 1348–1361 (2017).
Winther-Sørensen, M. et al. Mol. Metab. 42, 101080 (2020).
Mighiu, P. I. et al. Nat. Med. 19, 766–772 (2013).
LaPierre, M. P. et al. EMBO Rep. 16, 1299–1307 (2015).
Abraham, M. A. & Lam, T. K. T. Diabetologia 59, 1367–1371 (2016).
Strembitska, A. et al. Nat. Commun. 13, 5761 (2022).
Lamy, C. M. et al. Cell Metab. 19, 527–538 (2014).
Bankir, L. et al. Am. J. Physiol. Ren. Physiol. 311, 469–486 (2015).
Gerich, J. E. et al. Diabetes Care 24, 382–391 (2001).
Gautier-Stein, A. & Mithieux, G. Nat. Rev. Gastroenterol. Hepatol. https://doi.org/10.1038/s41575-022-00707-6 (2022).
Beaudry, J. L. et al. Mol. Metab. 22, 37–48 (2019).
Petersen, K. M. et al. J. Clin. Endocrinol. Metab. 103, 1804–1812 (2018).
Baggio, L. L. et al. Endocrinology 159, 1570–1584 (2018).
Capozzi, M. E. et al. JCI Insight 4, e126742 (2019).
Rorsman, P. & Huising, M. O. Nat. Rev. Endocrinol. 14, 404–414 (2018).
Zhang, Y. et al. Cells 10, 2495 (2021).
Suba, K. et al. Preprint at BioRxiv https://doi.org/10.1101/2022.09.01.506223 (2022).
Walker, J. N. et al. Diabetes Obes. Metab. 13, 95–105 (2011).
Gylfe, E. Upsala J. Med. Sci. 121, 120–132 (2016).
Acreman, S. & Zhang, Q. Chronic. Dis. Transl. Med. 8, 7–18 (2022).
Wendt, A. & Eliasson, L. Curr. Opin. Pharmacol. 63, 102199 (2021).
Dean, E. D. Diabetes 69, 542–549 (2019).
Zhang, Q., Dou, H. & Rorsman, P. J. Physiol. 598, 4765–4780 (2020).
Noguchi, G. M. & Huising, M. O. Nat. Metab. 1, 1189–1201 (2019).
Vergari, E. et al. Nat. Commun. 10, 139 (2019).
Göpel, S. O. et al. J. Physiol. 528, 509–520 (2000).
Pagliara, A. S. et al. J. Clin. Invest. 54, 819–832 (1974).
Olofsson, C. S. et al. Diabetes 56, 1888–1897 (2007).
Göpel, S. O. et al. J. Physiol. 528, 497–507 (2000).
Ramracheya, R. et al. Diabetes 59, 2198–2208 (2010).
Spigelman, A. F., Dai, X. & MacDonald, P. E. Diabetologia 53, 1917–1926 (2010).
Jacobson, D. & Shyng, S.-L. J. Mol. Biol. 432, 1326–1346 (2019).
Barg, S. et al. Diabetes 49, 1500–1510 (2000).
Liu, Y.-J., Vieira, E. & Gylfe, E. Cell Calcium 35, 357–365 (2004).
Hamilton, A. et al. Diabetes 67, 1128–1139 (2018).
Peterson, Q. P. et al. Nat. Commun. 11, 2241 (2020).
Basco, D. et al. Nat. Commun. 9, 546 (2018).
Bahl, V. et al. Mol. Metab. 49, 101193 (2020).
Briant, L. J. B. et al. Cell. Rep. 23, 3300–3311 (2018).
Quoix, N. et al. Diabetes 58, 412–421 (2009).
Hughes, J. W. et al. Diabetes Obes. Metab. 20, 127–136 (2018).
Yu, Q. et al. Diabetologia 62, 1212–1224 (2019).
Elliott, A. D., Ustione, A. & Piston, D. W. Am. J. Physiol. Endoc. M 308, E130–E143 (2015).
Singh, B., Khattab, F. & Gilon, P. Mol. Metab. 61, 101495 (2022).
Dai, X.-Q. et al. Cell Metab. 34, 256–268 (2022).
Omar-Hmeadi, M. et al. Nat. Commun. 11, 1896 (2020).
Dickerson, M. T. et al. Am. J. Physiol. Endoc. M 316, E646–E659 (2019).
Maruszczak, K. et al. Am. J. Physiol. Endoc. M 323, E207–E214 (2022).
Zhang, Q. et al. Cell Metab. 18, 871–882 (2013).
Unger, R. H. & Orci, L. Proc. Natl Acad. Sci. USA 107, 16009–16012 (2010).
Unger, R. H. & Cherrington, A. D. J. Clin. Invest. 122, 4–12 (2012).
Gerich, J. E. et al. Sci. New York 182, 171–173 (1973).
Bagger, J. I. et al. Diabetologia 57, 1720–1725 (2014).
Hare, K. J. et al. Am. J. Physiol. Endoc. M 298, E832–E837 (2010).
Müller, W. A. et al. New Engl. J. Med. 283, 109–115 (1970).
Lee, Y. et al. Diabetes 60, 391–397 (2011).
Henquin, J.-C., Ibrahim, M. M. & Rahier, J. Sci. Rep. 7, 11015 (2017).
Doliba, N. M. et al. J. Clin. Invest. 132, e156243 (2022).
Brissova, M. et al. Cell Rep. 22, 2667–2676 (2018).
Rahier, J., Goebbels, R. M. & Henquin, J. C. Diabetologia 24, 366–371 (1983).
Gubitosi-Klug, R. A. et al. J. Clin. Invest. 131, e143011 (2021).
Bosi, E. et al. iScience https://doi.org/10.2139/ssrn.4046141 (2022).
Avrahami, D. et al. Mol. Metab. 42, 101057 (2020).
Camunas-Soler, J. et al. Cell Metab. 31, 1017–1031 (2020).
Lernmark, Å. & Larsson, H. E. Nat. Rev. Endocrinol. 9, 92–103 (2013).
Yue, J. T. Y. et al. Diabetes 61, 197–207 (2011).
Karimian, N. et al. Diabetes 62, 2968–2977 (2013).
Farhat, R. et al. Diabetes Obes. Metab. 24, 908–917 (2022).
IHSG. Diabetologia 50, 1140–1147 (2007).
Alwafi, H. et al. Diabetes Res. Clin. Pr. 170, 108522 (2020).
Pettus, J. et al. Nat. Med. 28, 2092–2099 (2022).
Capozzi, M. E., D’Alessio, D. A. & Campbell, J. E. Cell Metab. 34, 1654–1674 (2022).
Hare, K. J. et al. Diabetes 59, 1765–1770 (2010).
Ramracheya, R. et al. Physiol. Rep. 6, e13852 (2018).
Blank, M. L. & Snyder, F. Meth. Enzymol. 197, 158–165 (1991).
Ørgaard, A. & Holst, J. J. Diabetologia 60, 1731–1739 (2017).
Gerich, J. E. et al. New Engl. J. Med. 291, 544–547 (1974).
Douros, A. et al. Diabetes Care 40, 1506–1513 (2017).
Cryer, P. E. Diabetes 63, 2188–2195 (2014).
Banarer, S., McGregor, V. P. & Cryer, P. E. Diabetes 51, 958–965 (2002).
Bowman, P. et al. Lancet Diabetes Endocrinol. 6, 637–646 (2017).
Proks, P., de Wet, H. & Ashcroft, F. M. Diabetes 62, 3909–3919 (2013).
Clemmensen, C. et al. Nat. Rev. Endocrinol. 15, 90–104 (2019).
Müller, T. D. et al. Nat. Rev. Drug Discov 21, 201–223 (2022).
Day, J. W. et al. Nat. Chem. Biol. 5, 749–757 (2009).
Pocai, A. et al. Diabetes 58, 2258–2266 (2009).
Finan, B. et al. Nat. Med. 21, 27–36 (2015).
Finan, B. et al. Sci. Transl. Med. 5, 209ra151 (2013).
Jastreboff, A. M. et al. New Engl. J. Med. 387, 205–216 (2022).
Frías, J. P. et al. New Engl. J. Med. 385, 503–515 (2021).
Frias, J. P. et al. Lancet 392, 2180–2193 (2018).
Nahra, R. et al. Diabetes Care 44, 1433–1442 (2021).
Parker, V. E. R. et al. Diabetes Obes. Metab. 24, 1360–1369 (2022).
Boland, M. L. et al. Nat. Metab. 2, 413–431 (2020).
Panzer, J. K., Tamayo, A. & Caicedo, A. Cell Rep. 41, 111792 (2022).
Tsien, R. Y. Biochemistry 67, 509–544 (1998).
Marinis, Y. Z. D. et al. Cell Metab. 11, 543–553 (2010).
Östenson, C.-G. et al. Diabetologia 29, 861–867 (1986).
Rudman, D. et al. Am. J. Clin. Nutr. 49, 559–566 (1989).
Frayn, K. N. Metabolic Regulation: A Human Perspective (John Wiley & Sons, 2009).
Panzer, J. K., Cohrs, C. M. & Speier, S. Meth. Mol. Biol. 2128, 301–312 (2020).
Speier, S. & Rupnik, M. Pflügers Archiv. 446, 553–558 (2003).
Yang, S.-N. & Berggren, P.-O. Pharmacol. Therapeut. 197, 103–121 (2019).
Bürger, M. & Brandt, W. Zeitschrift Für Die Gesamte Exp. Medizin. 96, 375–397 (1935).
Sutherland, E. W. & de Duve, C. J. Biol. Chem. 175, 663–674 (1948).
Staub, A., Sinn, L. & Behrens, O. K. J. Biol. Chem. 214, 619–632 (1955).
Bromer, W. W. et al. Diabetes 6, 234–238 (1957).
Unger, R. H. et al. J. Clin. Invest. 40, 1280–1289 (1961).
Exton, J. H. et al. Ann. NY Acad. Sci. 185, 85–100 (1971).
Bell, G. I. et al. Nature 304, 368–371 (1983).
Albrechtsen, N. J. W. et al. Diabetologia 57, 1919–1926 (2014).
Holst, J. J. & Albrechtsen, N. J. W. Int. J. Mol. Sci. 20, 5416 (2019).
MacDonald, P. E. et al. A PLoS. Biol. 5, e143 (2007).
Almaça, J. et al. Cell Rep. 17, 3281–3291 (2016).
Gromada, J. et al. J. Physiol. 535, 519–532 (2001).
Acknowledgements
P.E.M. holds the Canada Research Chair in Islet Biology and his work was funded by grants from the Canadian Institutes of Health Research (CIHR; FS 148451), the National Institutes of Health (NIH; R01DK126482; U01DK123716; U01DK120447) and CIHR/JDRF/Diabetes Canada (TG 179092; SRA-2021-1149-S-B). P.R.’s studies are supported by the RCUK Medical Research Council (MR/VO11979/1), The Leona M. and Harry B. Helmsley Charitable Trust (G-1912-03553 & G-2305-06047) and the Swedish Research Council (grant no: 2013-7107).
Author information
Authors and Affiliations
Contributions
P.R. and P.E.M. jointly wrote this article.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Metabolism thanks Nicolai Wewer Albrechtsen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary handling editor: Isabella Samuelson.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
MacDonald, P.E., Rorsman, P. Metabolic Messengers: glucagon. Nat Metab 5, 186–192 (2023). https://doi.org/10.1038/s42255-022-00725-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-022-00725-3